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detection using a novel pre- vs. post- operative specimen collection 
strategy coupled with modern proteomic methods. 
Methods: Serum samples were prepared from patients undergoing 
NSCLC resection - collected both before and 3-6 weeks after surgi-
cal intervention. Our prospective specimen collection efforts currently 
consists of ~ 98 NSCLC ‘paired’ (pre- and post operative) specimens; 
with ~ 54 benign ‘paired’ specimens for comparative purposes. A 
Ciphergen® SELDI-TOF mass spectrometer was used to generate 
the serum proteomic proﬁles, with data acquisition optimized for the 
5,000-40,000 m/z (mass) range. Spectral acquisitions were performed 
with albumin/IgG depleted samples that were concentrated via a 
reversed-phase matrix and collected in quadruplicate batches to further 
ensure reproducibility. Recrystallized a-cyanohydroxylcinnamic acid 
was used as the matrix. Spectral quality was assessed using PROcess a 
speciﬁc library within the Bioconductor R-project statistical platform 
(v2.2.0); with data analyses performed using the Signiﬁcance Analy-
sis of Microarray (SAM) algorithms; all in a blinded manner. Raw 
spectra were processed as follows: spectra pair normalization, baseline 
subtraction, and differential peak detection (with calibrated alignment). 
Aligned peaks were sorted into groups, based on tumor pathology and 
pre- vs. post-operative specimen type, and evaluated for relevance us-
ing a Wilcoxon signed-rank test. 
Results: Pre- and post-operative serum from 16 patients with lung SCC 
had their serum proteomes evaluated for signiﬁcant changes in com-
position. These values were then compared with a set of 10 ‘normal’ 
specimens (i.e. patients undergoing surgery for benign gynecologic or 
pulmonary disease). Even with our small sample size of our prelimi-
nary analysis, we identiﬁed 19 distinct serum components that were 
unique to the preoperative SCC patients, with p<0.05 and a 9.77% 
rate of false discovery. Further, we revealed 13 components that were 
signiﬁcantly reduced or absent (q< 0.05) after tumor resection, with a 
false discovery threshold of 11.14%. From this group, species at m/z 
values of 5336.71, 8587.11, 8842.49, and 14,014.7 seem most promis-
ing, based on their high level of signiﬁcance (q < 0.02). 
Conclusions: These results validate the power of our ‘pre- vs. post- op-
erative’ specimen sets for the identiﬁcation of novel serum biomarker 
candidates for lung squamous cell carcinoma. Efforts are currently fo-
cused on increasing our bank of patient specimens, expanding the study 
to patients with other NSCLC histological sub-types, and identifying 
the reported biomarker candidates via tandem mass spectrometry.
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Background: Reactive Oxygen Species (ROS) are byproducts of 
cellular metabolism. Excess production of ROS originating either 
endogenous or exogenous sources is shown to be a major player in the 
pathogenesis of many diseases as non-small cell lung cancer (NSCLC). 
Knowledge of the difference in ROS between adenocarcinoma (AC) 
and squamous cell carcinoma (SCC) is sparse. The aim of this study 
was to assess the interactions between different markers of oxidative 
stress and compare the results between AC and SCC.
Methods: Twenty eight patients underwent surgery due to a lung or 
a pleural disease. Patients were categorized into three groups: control 
group (N=10) including seven with recurrent pneumothorax, two ham-
artoma and one vascular anomaly, AC (N=11), and SCC (N=7) of the 
lung. For patients with malignant disease, analysis included both the 
tumor and a sample from the resected normal lung tissue. Following 
measurements were analyzed collectively from the samples: myeloper-
oxidase (MP) activity by the amount of oxidation of 3,3’, 5,5’-tetra-
methylbenzidine, glutathione content by Saville’s method, the NADPH 
oxidase activity by lucigenin-enhanced chemiluminescent detection, 
and the amount 8-oxo-dG using HPLC. 
Results: Results are presented in Table 1. 
Conclusion: The present study revealed, especially in AC, increased 
gluthione content and NAPDH oxidase activity, and decreased myelo-
peroxidase activity together with decreased levels of 8-oxo-dG. The 
level of oxidative stress and antioxidant defense seems to be different 
between AC and SCC.
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Promoter methylation is an important mechanism for silencing tumor-
suppressor genes in cancer and it is a promising tool for the develop-
ment of molecular biomarkers. The purpose of the present study was 
to investigate whether inactivation of the A Kinase Anchoring Protein 
12 α (AKAP12α) gene is associated with promoter methylation in lung 
